A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy Post author: Post published:October 11, 2023 Post category:uncategorized The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults. You Might Also Like New tool predicts health risks from heat and cold waves June 26, 2024 Risk factors for faster aging in the brain revealed in new study March 27, 2024 Are all fats equal in heart disease risk? New veteran study suggests not October 16, 2023